Stay updated on TNO155 Combinations Clinical Trial
Sign up to get notified when there's something new on the TNO155 Combinations Clinical Trial page.

Latest updates to the TNO155 Combinations Clinical Trial page
- Check7 days agoChange DetectedStudy design, eligibility criteria, and listed locations are unchanged between the screenshots. Only user-interface layout changes and updated timestamps are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA note clarifying that PubMed publications listed on the page may not be about the study. The revision number has been updated to v3.3.2.SummaryDifference0.2%

- Check28 days agoChange DetectedA general site-wide funding-status notice has been removed from the page.SummaryDifference0.4%

- Check42 days agoChange DetectedThe page continues to present the Phase Ib study details of TNO155 in combination with Spartalizumab or Ribociclib. Any observed changes are limited to administrative metadata, not the main study content.SummaryDifference0.4%

- Check56 days agoChange DetectedNo significant changes detected.SummaryDifference0.6%

- Check71 days agoChange DetectedUpdates include new operating status notices, a new plain language trial summary link, and a new revision/version (v3.2.0) with forward-dated dates; older dates and revision (v3.1.0) removed.SummaryDifference5%

Stay in the know with updates to TNO155 Combinations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNO155 Combinations Clinical Trial page.